Glomerulonephritis, Poststreptococcal Follow-up

  • Author: Duvuru Geetha, MD, MRCP; Chief Editor: Vecihi Batuman, MD, FACP, FASN   more...
 
Updated: Apr 13, 2010
 

Further Inpatient Care

  • In the acute phase, admit for observation and treatment of hypertension and congestive heart failure.
  • Admit for monitoring and to initiate dialysis (when indicated) if renal function progressively worsens.
Next

Further Outpatient Care

  • Monitor blood pressure every month for 6 months and then every 6 months thereafter.
  • Monitor BUN and serum creatinine levels every 3 months after the acute phase for 1 year and then yearly after that.
  • Check serum complement levels at 6-8 weeks to make sure they have returned to normal.
  • Check urine for hematuria and proteinuria every 3-6 months.
Previous
Next

Inpatient & Outpatient Medications

  • Most patients do not require any medications after the acute phase.
  • In the acute phase, diuretics may be needed to control edema and congestive heart failure.
  • Antihypertensives may be needed in the chronic phase if the patient's blood pressure remains high.
Previous
Next

Transfer

  • Transfer may be necessary if renal biopsy facilities are not available and the diagnosis is in doubt or if rapidly progressive renal failure develops.
  • Transfer may be necessary if azotemia worsens and dialysis facilities are not available on site.
Previous
Next

Deterrence/Prevention

  • The patient and any family member or close personal contact should have a throat culture.
  • Treatment with penicillin G or erythromycin (if allergic to penicillin) helps prevent nephritis in carriers and helps prevent the spread of nephritogenic strains to others.
  • Patients with skin infections must pay close attention to personal hygiene.
  • Epidemics should prompt empirical prophylactic treatment for high-risk individuals (family and close personal contacts).
Previous
Next

Complications

  • Complications in the acute phase include the following:
    • Congestive heart failure
    • Azotemia
    • Early death secondary to congestive heart failure and azotemia
  • Complications in the chronic phase include the following:
    • Nephrotic-range proteinuria
    • Chronic renal insufficiency and end-stage renal disease
Previous
Next

Prognosis

  • In children, the immediate prognosis is excellent.[2]
  • In elderly patients who have congestive heart failure or azotemia in the early phase, early mortality rates can be as high as 25%.
  • The long-term prognosis is debatable.
    • Fewer than 1% of children have elevated serum creatinine values after 10-15 years of follow-up.
    • Adults who develop massive proteinuria often have the garlandlike pattern of immune deposits. Their prognosis is worse; approximately 25% progress to chronic renal failure.
Previous
Next

Patient Education

Previous
 
Contributor Information and Disclosures
Author

Duvuru Geetha, MD, MRCP  Assistant Professor of Medicine, Department of Renal Medicine, Bayview Medical Center, Johns Hopkins University

Duvuru Geetha, MD, MRCP is a member of the following medical societies: American Society of Nephrology and International Society of Nephrology

Disclosure: Nothing to disclose.

Specialty Editor Board

Chike Magnus Nzerue, MD  Associate Dean for Clinical Affairs, Vice-Chairman of Internal Medicine, Meharry Medical College

Chike Magnus Nzerue, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Society of Nephrology, and National Kidney Foundation

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Ajay K Singh, MB, MRCP, MBA  Associate Professor of Medicine, Harvard Medical School; Clinical Chief, Renal Division, Director of Dialysis, Brigham and Women's Hospital; Consulting Staff, Faulkner Hospital

Disclosure: Nothing to disclose.

Rebecca J Schmidt, DO, FACP, FASN  Professor of Medicine, Section Chief, Department of Medicine, Section of Nephrology, West Virginia University School of Medicine

Rebecca J Schmidt, DO, FACP, FASN is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Nephrology, International Society of Nephrology, National Kidney Foundation, Renal Physicians Association, and West Virginia State Medical Association

Disclosure: Abbott Grant/research funds Speaking and teaching; AMAG Honoraria Speaking and teaching; Amgen Honoraria Speaking and teaching; Ortho Biotech Honoraria Speaking and teaching; Renal Ventures Ownership interest Other

Chief Editor

Vecihi Batuman, MD, FACP, FASN  Professor of Medicine, Section of Nephrology-Hypertension, Tulane University School of Medicine; Chief, Medicine Service, Southeast Louisiana Veterans Health Care System

Vecihi Batuman, MD, FACP, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, and International Society of Nephrology

Disclosure: Nothing to disclose.

References
  1. Zegers RH, Weigl A, Steptoe A. The death of Wolfgang Amadeus Mozart: an epidemiologic perspective. Ann Intern Med. Aug 18 2009;151(4):274-8, W96-7. [Medline].

  2. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. Oct 2008;19(10):1855-64. [Medline].

  3. Ahn SY, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. Apr 2008;20(2):157-62. [Medline].

  4. Wu SH, Liao PY, Yin PL, Zhang YM, Dong L. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol. Jan 2009;174(1):115-22. [Medline]. [Full Text].

  5. Oda T, Tamura K, Yoshizawa N, et al. Elevated urinary plasmin activity resistant to alpha2-antiplasmin in acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant. Jul 2008;23(7):2254-9. [Medline].

  6. Bakr A, Mahmoud LA, Al-Chenawi F, et al. HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr Nephrol. Mar 2007;22(3):376-9. [Medline].

  7. Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. Jul 2008;23(7):1101-6. [Medline].

  8. Parra G, Rodriguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. Aug 1998;54(2):509-17. [Medline].

  9. Taskesen M, Taskesen T, Katar S, et al. Elevated plasma levels of N-terminal pro-brain natriuretic peptide in children with acute poststreptococcal glomerulonephritis. Tohoku J Exp Med. Apr 2009;217(4):295-8. [Medline]. [Full Text].

  10. Sorger K, Gessler U, Hubner FK, et al. Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol. Mar 1982;17(3):114-28. [Medline].

  11. Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?. Kidney Int. Sep 2005;68(3):1120-9. [Medline].

  12. Dedeoglu IO, Springate JE, Waz WR, et al. Prolonged hypocomplementemia in poststreptococcal acute glomerulonephritis. Clin Nephrol. Nov 1996;46(5):302-5. [Medline].

  13. Deen WM, Bridges CR, Brenner BM. Biophysical basis of glomerular permselectivity. J Membr Biol. 1983;71(1-2):1-10. [Medline].

  14. Dorrington KJ, Tanford C. Molecular size and conformation of immunoglobulins. Adv Immunol. 1970;12:333-81. [Medline].

  15. Massry SG, Glassock RJ. Glomerulonephritis associated with infection. In: Massry SG, Glasscock RJ, eds. Textbook of Nephrology. 3rd ed. Baltimore, Md: Williams & Wilkins; 1995:698-703.

  16. Rodriguez-Iturbe B. Postinfectious glomerulonephritis. Am J Kidney Dis. Jan 2000;35(1):XLVI-XLVIII. [Medline].

  17. Shrier RW, Gottschalk CW, eds. Diseases of the Kidney. Vol 2. 6th ed. Boston, Mass: Little, Brown & Company; 1997:1579- 84.

  18. Silva FG. Acute postinfectious glomerulonephritis and glomerulonephritis complicating persistent bacterial infection. In: Jennette JC, Olson JL, Schwartz MM, eds. Heptinstall's Pathology of the Kidney. Vol 1. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998:389-455.

  19. Wiwanitkit V. Why is acute post-streptococcal glomerulonephritis more common in the pediatric population?. Clin Exp Nephrol. Jun 2006;10(2):164. [Medline].

Previous
Next
 
Diagram of a nephron.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.